• Publications
  • Influence
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Background Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all‐cause mortality may guide interventions. Methods andExpand
  • 108
  • 4
  • PDF
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
BackgroundReal-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinicalExpand
  • 7
[PP.14.36] LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION FOR PROGNOSIS OF SUDDEN CARDIAC DEATH IN PATIENTS WITH MYOCARDIAL INFARCTION
Objective: Evaluation of left ventricular hypertrophy and dyastolic dysfunction as risk factors of sudden death (SCD) among patients with myocardial infarction (MI) Design and method: 300 pts. withExpand
POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE
Aim. To evaluate the functional activity of platelets by the optical standard aggregatometry and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acidExpand